233 related articles for article (PubMed ID: 33449093)
1. Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV.
Nir TM; Fouche JP; Ananworanich J; Ances BM; Boban J; Brew BJ; Chaganti JR; Chang L; Ching CRK; Cysique LA; Ernst T; Faskowitz J; Gupta V; Harezlak J; Heaps-Woodruff JM; Hinkin CH; Hoare J; Joska JA; Kallianpur KJ; Kuhn T; Lam HY; Law M; Lebrun-Frénay C; Levine AJ; Mondot L; Nakamoto BK; Navia BA; Pennec X; Porges EC; Salminen LE; Shikuma CM; Surento W; Thames AD; Valcour V; Vassallo M; Woods AJ; Thompson PM; Cohen RA; Paul R; Stein DJ; Jahanshad N
JAMA Netw Open; 2021 Jan; 4(1):e2031190. PubMed ID: 33449093
[TBL] [Abstract][Full Text] [Related]
2. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
Sanford R; Fellows LK; Ances BM; Collins DL
JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
[TBL] [Abstract][Full Text] [Related]
3. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood.
Ruiz-Saez B; García MM; de Aragon AM; Gil-Correa M; Melero H; Malpica NA; de Ory SJ; Zamora B; Guillen S; Rojo P; Falcon-Neyra L; Alvarez A; Fernandez P; Lorente-Jareño ML; Ramos JT; Sainz T; Velo C; Navarro ML; Gonzalez-Tomé MI;
Medicine (Baltimore); 2021 Apr; 100(15):e25403. PubMed ID: 33847637
[TBL] [Abstract][Full Text] [Related]
4. CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention.
Govender S; Otwombe K; Essien T; Panchia R; de Bruyn G; Mohapi L; Gray G; Martinson N
PLoS One; 2014; 9(3):e90754. PubMed ID: 24595317
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
6. Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.
Ndumbi P; Falutz J; Pant Pai N; Tsoukas CM
PLoS One; 2014; 9(4):e94018. PubMed ID: 24710051
[TBL] [Abstract][Full Text] [Related]
7. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
[TBL] [Abstract][Full Text] [Related]
8. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B;
J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960
[TBL] [Abstract][Full Text] [Related]
9. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
10. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
[TBL] [Abstract][Full Text] [Related]
11. Progressive brain atrophy in chronically infected and treated HIV+ individuals.
Nir TM; Jahanshad N; Ching CRK; Cohen RA; Harezlak J; Schifitto G; Lam HY; Hua X; Zhong J; Zhu T; Taylor MJ; Campbell TB; Daar ES; Singer EJ; Alger JR; Thompson PM; Navia BA;
J Neurovirol; 2019 Jun; 25(3):342-353. PubMed ID: 30767174
[TBL] [Abstract][Full Text] [Related]
12. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
[TBL] [Abstract][Full Text] [Related]
13. Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD).
Egger S; Petoumenos K; Kamarulzaman A; Hoy J; Sungkanuparph S; Chuah J; Falster K; Zhou J; Law MG;
J Acquir Immune Defic Syndr; 2009 Apr; 50(5):513-20. PubMed ID: 19408354
[TBL] [Abstract][Full Text] [Related]
14. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Agwu AL; Warshaw MG; McFarland EJ; Siberry GK; Melvin AJ; Wiznia AA; Fairlie L; Boyd S; Harding P; Spiegel HML; Abrams EJ; Carey VJ;
PLoS One; 2017; 12(6):e0178075. PubMed ID: 28604824
[TBL] [Abstract][Full Text] [Related]
15. HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.
Kallianpur KJ; Valcour VG; Lerdlum S; Busovaca E; Agsalda M; Sithinamsuwan P; Chalermchai T; Fletcher JL; Tipsuk S; Shikuma CM; Shiramizu BT; Ananworanich J;
AIDS; 2014 Jul; 28(11):1619-24. PubMed ID: 25232899
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Pollard RB; Rockstroh JK; Pantaleo G; Asmuth DM; Peters B; Lazzarin A; Garcia F; Ellefsen K; Podzamczer D; van Lunzen J; Arastéh K; Schürmann D; Clotet B; Hardy WD; Mitsuyasu R; Moyle G; Plettenberg A; Fisher M; Fätkenheuer G; Fischl M; Taiwo B; Baksaas I; Jolliffe D; Persson S; Jelmert O; Hovden AO; Sommerfelt MA; Wendel-Hansen V; Sørensen B
Lancet Infect Dis; 2014 Apr; 14(4):291-300. PubMed ID: 24525316
[TBL] [Abstract][Full Text] [Related]
17. Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV.
Wade BSC; Valcour VG; Puthanakit T; Saremi A; Gutman BA; Nir TM; Watson C; Aurpibul L; Kosalaraksa P; Ounchanum P; Kerr S; Dumrongpisutikul N; Visrutaratna P; Srinakarin J; Pothisri M; Narr KL; Thompson PM; Ananworanich J; Paul RH; Jahanshad N;
Neuroimage Clin; 2019; 23():101810. PubMed ID: 31029050
[TBL] [Abstract][Full Text] [Related]
18. Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.
Shoko C; Chikobvu D; Bessong PO
Pak J Biol Sci; 2020 Mar; 23(4):542-551. PubMed ID: 32363840
[TBL] [Abstract][Full Text] [Related]
19. Validation of CD4
Cassenote AJF; Grangeiro A; Escuder MM; Abe JM; Segurado AAC
BMC Infect Dis; 2018 Dec; 18(1):617. PubMed ID: 30514215
[TBL] [Abstract][Full Text] [Related]
20. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
